| 注册
首页|期刊导航|中国医学伦理学|放射性药物临床研究的伦理问题及思考

放射性药物临床研究的伦理问题及思考

胡永兰 王力 江凤 周吉银 陈正君 张洁 张增瑞

中国医学伦理学2025,Vol.38Issue(2):254-260,7.
中国医学伦理学2025,Vol.38Issue(2):254-260,7.DOI:10.12026/j.issn.1001-8565.2025.02.17

放射性药物临床研究的伦理问题及思考

Ethical issues and reflections on clinical research of radiopharmaceuticals

胡永兰 1王力 2江凤 3周吉银 4陈正君 5张洁 5张增瑞5

作者信息

  • 1. 叙永县人民医院科研教学部,四川 泸州 646000
  • 2. 核医学与分子影像四川省重点实验室,四川 泸州 646000
  • 3. 西南医科大学附属医院国家药物临床试验机构,四川 泸州 646000
  • 4. 陆军军医大学第二附属医院临床医学研究中心,重庆 400037
  • 5. 西南医科大学附属医院临床试验伦理委员会,四川 泸州 646000
  • 折叠

摘要

Abstract

Radiopharmaceuticals play an important role in the diagnosis and treatment of cardiovascular and cerebrovascular diseases,malignant tumors,central nervous system diseases,and other diseases.Under the urgent need for clinical diagnosis and treatment as well as medical development,the clinical research of radiopharmaceuticals has become a hotspot in international research.By analyzing the current situation of clinical research on radiopharmaceuticals in Europe,America,and China,the ethical issues of clinical research on radiopharmaceuticals were elaborated from four aspects,including lack of relevant laws and regulations,a higher risk of radiopharmaceuticals,dilemmas in ethical review,and insufficient radiation protection.Response principles and measures were proposed from four aspects,including improving regulations and policies,enhancing radiological protection for all parties involved in the research,strengthening ethical review,and reinforcing the training of relevant personnel,to enhance the quality and level of clinical research on radiopharmaceuticals.

关键词

放射性药物/临床研究/伦理审查

Key words

radiopharmaceutical/clinical research/ethical review

分类

医药卫生

引用本文复制引用

胡永兰,王力,江凤,周吉银,陈正君,张洁,张增瑞..放射性药物临床研究的伦理问题及思考[J].中国医学伦理学,2025,38(2):254-260,7.

基金项目

2024年叙永县人民医院西南医科大学科技战略合作项目"基于医疗联合体的泸州市区域伦理委员会建设的探索"(2024XYXNYD16) (2024XYXNYD16)

中国医学伦理学

OA北大核心

1001-8565

访问量10
|
下载量0
段落导航相关论文